C.T. Lamont Primary Health Care Research Centre, Bruyère Research Institute, Ottawa, ON, Canada.
Department of Family Medicine, University of Ottawa, Ottawa, ON, Canada.
HIV Med. 2019 Feb;20(2):88-98. doi: 10.1111/hiv.12682. Epub 2018 Nov 26.
Selection as a consequence of volunteer participation in, and loss to follow-up from, cohort studies may bias estimates of mortality and other health outcomes. To quantify this potential, we estimated mortality and health service use among people living with HIV (PLWH) who were lost to cohort follow-up (LTCFU) from a volunteer clinical HIV-infected cohort, and compared these to mortality and health service use in active cohort participants and non-cohort-participants living with HIV in Ontario, Canada.
We analysed population-based provincial health databases from 1995 to 2014, identifying PLWH ≥ 18 years old; these included data from participants in the Ontario HIV Treatment Network Cohort Study (OCS), a volunteer, multi-site clinical HIV-infected cohort. We calculated all-cause mortality, hospitalization and emergency department (ED) visit rates per 100 person-years (PY) and estimated hazard ratios (HRs) of mortality, adjusting for age, sex, income, rurality, and immigration status.
Among 23 043 PLWH, 5568 were OCS participants. Compared with nonparticipants, participants were younger and less likely to be female, to be an immigrant and to reside in a major urban centre, and had lower comorbidity. Mortality among active participants, participants LTCFU and nonparticipants was 2.52, 3.30 and 2.20 per 100 PY, respectively. After adjustment for covariates, mortality risk was elevated among participants LTCFU compared with active participants (HR 2.26; 95% confidence interval 1.91, 2.68). Age-adjusted hospitalization rates and ED visit rates were highest among participants LTCFU.
Mortality risk and use of health care resources were lower among active cohort participants. Our findings may inform health outcome estimates based on volunteer cohorts, as well as quantitative bias adjustment to correct for such biases.
由于志愿者参与和失访,队列研究的选择可能会使死亡率和其他健康结果的估计值产生偏差。为了量化这种潜在的偏差,我们估计了从一个志愿者临床 HIV 感染队列中失访的 HIV 感染者(PLWH)的死亡率和卫生服务利用情况,并将这些结果与安大略省活跃队列参与者和非队列参与者的死亡率和卫生服务利用情况进行了比较。
我们分析了 1995 年至 2014 年基于人群的省级卫生数据库,确定了年龄≥18 岁的 PLWH;这些数据包括来自安大略省 HIV 治疗网络队列研究(OCS)的参与者的数据,OCS 是一个志愿者、多地点临床 HIV 感染队列。我们计算了每 100 人年(PY)的全因死亡率、住院率和急诊部(ED)就诊率,并根据年龄、性别、收入、农村和移民状况调整了死亡率的风险比(HRs)。
在 23043 名 PLWH 中,有 5568 名是 OCS 参与者。与非参与者相比,参与者更年轻,女性比例更低,移民比例和居住在主要城市中心的比例更低,合并症更少。活跃参与者、失访参与者和非参与者的死亡率分别为每 100 PY 2.52、3.30 和 2.20。调整协变量后,失访参与者的死亡率风险高于活跃参与者(HR 2.26;95%置信区间 1.91,2.68)。调整年龄后的住院率和 ED 就诊率在失访参与者中最高。
活跃队列参与者的死亡率风险和卫生资源利用较低。我们的发现可能会影响基于志愿者队列的健康结果估计,并纠正这种偏差的定量偏差调整。